The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.

SMJ // Article

Review Article

When HbA1c Lies: Recognizing and Managing HbA1c-Glucose Discordance in Clinical Practice

Authors: Brian Burroughs, MSPAS, PA-C, AQH, BC-ADM, CDCES, CHC

Abstract

Hemoglobin A1c (HbA1c) remains a cornerstone of glycemic assessment in diabetes mellitus care, yet discordance between HbA1c and measured glucose values is common in clinical practice. Failure to recognize this discordance can lead to inappropriate treatment escalation, increased hypoglycemia risk, and patient distress. This article reviews the biological and clinical factors that contribute to HbA1c-glucose discordance and translates these findings into practical strategies for routine care. Common causes include iron deficiency, chronic kidney disease, altered red blood cell turnover, hemoglobin variants, and rapid changes in glycemia. A stepwise, practice-oriented framework is presented to guide clinicians in evaluating discordant glycemic data using targeted laboratory testing and continuous glucose monitoring metrics. Emphasis is placed on avoiding reflexive medication intensification and using glucose monitoring data to individualize treatment decisions. The role of interdisciplinary care and patient-centered communication is also highlighted.

 
Posted in: Endocrinology, Diabetes, and Metabolism42

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. American Diabetes Association Professional Practice Committee. 6. Glycemic goals, hypoglycemia, and hyperglycemic crises: Standards of Care in Diabetes-2026. Diabetes Care 2026;49( Suppl 1 ):S132-S149.
 
2. Sureshkumar P, Kumar SS, Anusree E, et al. Navigating the discordance: a comprehensive review of HbA1c-glycemia mismatch in clinical practice. Diabetes Res Clin Pract 2026;235:113216.
 
3. Davies MJ, Aroda VR, Collins BS, et al. Management of hyperglycemia in type 2 diabetes, 2022: a consensus report by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2022;45:2753-2786.
 
4. American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes-2026. Diabetes Care 2026;49( Suppl 1 ):S27-S49.
 
5. Davies MJ, D’Alessio DA, Fradkin J, et al. Management of hyperglycemia in type 2 diabetes, 2018: a consensus report by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2018;41:2669-2701.
 
6. Gomez-Peralta F, Choudhary P, Cosson E, et al. Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin. Diabetes Obes Metab 2022;24:599-608.
 
7. American Diabetes Association Professional Practice Committee. 13. Older adults: Standards of Care in Diabetes-2026. Diabetes Care 2026;49( Suppl 1 ):S277-S296.
 
8. Bergenstal RM, Martens TW, Beck RW. Continuous glucose monitoring. JAMA 2025;334:2220-2222.
 
9. Kidney Disease: Improving Global Outcomes Diabetes Work Group. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int 2022;102( 5S ):S1-S127.
 
10. Galindo RJ, Beck RW, Scioscia MF, et al. Glycemic monitoring and management in advanced chronic kidney disease. Endocr Rev 2020;41:bnaa017.
 
11. Yapanis M, James S, Craig ME, et al. Complications of diabetes and metrics of glycemic management derived from continuous glucose monitoring. J Clin Endocrinol Metab 2022;107:e2221-e2236.
 
12. Department of Veterans Affairs, Department of Defense. VA/DoD clinical practice guideline. Management of type 2 diabetes mellitus 2023. https://www.healthquality.va.gov/guidelines/cd/diabetes. Accessed March 21, 2026.
 
13. Daya NR, Fang M, Shin JI, et al. Detecting hyperglycemia using biomarkers versus continuous glucose monitoring. Diabetes Care 2025;48:1446-1452.
 
14. Selvin E. The glucose management indicator: time to change course? Diabetes Care 2024;47:906-914.
 
15. Kalyani RR, Neumiller JJ, Maruthur NM, et al. Diagnosis and treatment of type 2 diabetes in adults: a review. JAMA 2025;334:984-1002.